FIELD: medicine; dermatology.
SUBSTANCE: invention can be used in treating atopic dermatitis (AD). Method involves administering tradipitant 170 mg/day to a patient with mild AD.
EFFECT: use of the invention enables to achieve a significant reduction in itching in the patients with mild AD.
5 cl, 1 tbl, 9 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT | 2018 |
|
RU2812890C2 |
METHODS OF TREATING ATOPIC DERMATITIS WITH THE HELP OF IL-4R ANTAGONIST | 2013 |
|
RU2698907C2 |
METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING IL-4R ANTAGONIST | 2013 |
|
RU2666630C2 |
IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT | 2018 |
|
RU2793237C2 |
METHOD FOR TREATMENT OF GASTROINTESTINAL TRACT DISEASES WITH TRADIPITANT | 2018 |
|
RU2797248C2 |
METHOD OF TREATING SKIN INFECTION BY ADMINISTERING ANTAGONIST IL-4R | 2015 |
|
RU2704999C2 |
USE OF IL-13 ANTAGONISTS FOR THE TREATMENT OF ATOPIC DERMATITIS | 2017 |
|
RU2752785C2 |
METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR | 2017 |
|
RU2759630C2 |
METHOD OF TREATMENT OF ATOPIC DERMATITIS THROUGH INTRODUCTION OF IL-4R INHIBITOR | 2019 |
|
RU2801204C2 |
METHOD OF TREATING USING TRADIPITANT | 2016 |
|
RU2770050C2 |
Authors
Dates
2024-04-25—Published
2021-02-24—Filed